Plasma biomarkers of Alzheimer's disease and related dementias in American Indians: The Strong Heart Study
Alzheimer's & Dementia · 2024-03 · 20 (3) · 2072-2079
DOI: 10.1002/alz.13664 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 12.01.2024. Verfasst von Astrid M Suchy-Dicey und 8 weiteren Autor:innen. Beteiligte Einrichtung: Washington State University Elson S Floyd College of Medicine, Spokane, Washington, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, American Indian or Alaska Native. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMHD NIH HHS, NHLBI NIH HHS, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Identification of Alzheimer's disease (AD) needs inexpensive, noninvasive biomarkers, with validation in all populations. METHODS We collected plasma markers in older American Indian individuals: phosphorylated‐tau181 (pTau181); amyloid‐beta (Aβ) 40,42; glial fibrillary acidic protein (GFAP); and neurofilament light chain (NfL). Plasma markers were analyzed for discriminant properties with cognitive status and etiology using receiver operating characteristic (ROC) analysis. RESULTS PTau181, GFAP, NfL plasma values were significantly associated with cognition, but Aβ were not. Discriminant performance was moderate for individual markers, with pTau181, GFAP, NfL performing best, but an empirically selected panel of markers (age, sex, education, pTau181, GFAP, NfL, Aβ4240 ratio) had excellent discriminant performance (AUC > 0.8). DISCUSSION In American Indian individuals, pTau181 and Aβ values suggested more common pathology than in majority populations. Aβ was less informative than in other populations; however, all four markers were needed for a best‐performing dementia diagnostic model. These data validate utility of AD plasma markers, while suggesting population‐specific diagnostic characteristics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Washington State University Elson S Floyd College of Medicine, Spokane, Washington, USA.
- Huntington Medical Research Institutes, Pasadena, California, USA.
- Washington State University Institute for Research and Education to Address Community Health, Seattle, Washington, USA.
- University of Washington Alzheimer's Disease Research Center, Seattle, Washington, USA.
- Department of Neurology, University of Washington, Seattle, Washington, USA.
- MedStar Health Research Institute, Hyattsville, Maryland, USA.
ORCID-Profile: Astrid M Suchy-Dicey
Förderung
- NIMHD NIH HHS
- NHLBI NIH HHS
- NIA NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Suchy-Dicey, A. M., Longstreth, W. T., Rhoads, K., Umans, J., Buchwald, D., Grabowski, T., Blennow, K., Reiman, E., & Zetterberg, H. (2024). Plasma biomarkers of Alzheimer's disease and related dementias in American Indians: The Strong Heart Study. Alzheimer's & Dementia, 20(3), 2072-2079. https://doi.org/10.1002/alz.13664
Vancouver
Suchy-Dicey AM, Longstreth WT, Rhoads K, Umans J, Buchwald D, Grabowski T, et al. Plasma biomarkers of Alzheimer's disease and related dementias in American Indians: The Strong Heart Study. Alzheimer's & Dementia. 2024;20(3):2072-2079. doi:10.1002/alz.13664
BibTeX
@article{SuchyDicey2024,
author = {Suchy-Dicey, Astrid M and Longstreth, W T and Rhoads, Kristoffer and Umans, Jason and Buchwald, Dedra and Grabowski, Thomas and Blennow, Kaj and Reiman, Eric and Zetterberg, Henrik},
title = {Plasma biomarkers of Alzheimer's disease and related dementias in American Indians: The Strong Heart Study},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {3},
pages = {2072--2079},
doi = {10.1002/alz.13664}
}
EUVIMED